Stay updated on Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial
Sign up to get notified when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.

Latest updates to the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page
- Check3 days agoChange DetectedRecruitment status was updated to No longer looking for participants, indicating the study is not actively enrolling. The history shows a new revision (v3.6.0) and the previous revision (v3.5.5) has been removed to reflect the latest version of the record.SummaryDifference0.4%

- Check11 days agoChange DetectedA new revision entry (v3.5.5) was added to the study record history, updating the version history to reflect the latest revision. This change updates the historical log rather than the actual study data or visible content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe Record History adds the latest revision v3.5.4, replacing v3.5.3. This reflects a small metadata update to the page's revision log rather than substantive changes to the study record.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry v3.5.3 has been added to the record history, and the previous v3.5.2 entry has been removed. This updates the page’s release notes in the history log.SummaryDifference0.1%

- Check61 days agoChange DetectedA new revision entry (v3.5.2) was added to the history. The previous revision entry (v3.5.0) was removed.SummaryDifference0.1%

- Check89 days agoChange DetectedThe record history now includes Revision v3.5.0 and omits Revision v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.